China Medical System debuts on SGX

This marks the group’s second market listing.

China Medical System Holdings Limited (CMS), a pharmaceutical company focused on drug innovation and commercialisation, has made its debut on the Singapore Exchange’s Mainboard (SGX-ST) under the symbol “8A8.”

This marks its second stock market listing, following its debut on the Stock Exchange of Hong Kong Limited (HKEX) in 2010.

The Singapore listing did not involve issuing new shares. CGS International Securities Singapore Pte. Ltd. served as the sole issue manager for the listing.

As of 15 July, the group’s market capitalisation stood at $5.2b (HK$31.91b).

The company said it is pushing ahead with commercialisation plans for five drugs and expects two more innovative products to gain approval in China in FY2025.

It also noted efforts to expand its business, supported by product differentiation and expansion to products with consumer attributes and a more proactive execution of its integrated omnichannel marketing strategies.

“To meet the growing pharmaceutical demand, our CDMO facility is planning to expand its manufacturing capability to include nasal spray platforms, cream, and injectable lines beyond its current focus on oral solid dosage forms,” CMS said.

It is also considering a major scale-up of its overall manufacturing capacity by the end of 2028.

($1 = HK$6.11)

Follow the link for more news on

SGX

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia